Effectiveness of clotting factor replacement therapy after antivenom treatment on coagulopathic envenomation following green pit viper bites: a retrospective observational study

[1]  J. Gutiérrez.  Global Availability of Antivenoms: The Relevance of Public Manufacturing Laboratories , 2018, Toxins.

[2]  R. Cardigan,et al.  British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding , 2018, British journal of haematology.

[3]  A. Boloor,et al.  The role of fresh frozen plasma in reducing the volume of anti-snake venom in snakebite envenomation , 2018, Tropical doctor.

[4]  S. Kularatne,et al.  Epidemiology and clinical features of Green pit viper (Trimeresurus trigonocephalus) envenoming in Sri Lanka , 2017, Toxicon : official journal of the International Society on Toxinology.

[5]  K. Weant,et al.  Delayed hematologic toxicity following rattlesnake envenomation unresponsive to crotalidae polyvalent antivenom. , 2017, The American journal of emergency medicine.

[6]  H. J. de Silva,et al.  A randomized controlled trial of fresh frozen plasma for coagulopathy in Russell's viper (Daboia russelii) envenoming , 2017, Journal of thrombosis and haemostasis : JTH.

[7]  K. M. Poon,et al.  Comparison of green pit viper and Agkistrodon halys antivenom in inhibition of coagulopathy due to Trimeresurus albolabris venom: an in-vitro study using human plasma. , 2016, Hong Kong medical journal = Xianggang yi xue za zhi.

[8]  G. Isbister,et al.  Intracranial haemorrhages associated with venom induced consumption coagulopathy in Australian snakebites (ASP-21). , 2015, Toxicon : official journal of the International Society on Toxinology.

[9]  K. Maduwage,et al.  Current Treatment for Venom-Induced Consumption Coagulopathy Resulting from Snakebite , 2014, PLoS neglected tropical diseases.

[10]  C. Jeong,et al.  Atraumatic splenic rupture after coagulopathy owing to a snakebite. , 2014, Wilderness & environmental medicine.

[11]  N. Buckley,et al.  A randomized controlled trial of fresh frozen plasma for treating venom‐induced consumption coagulopathy in cases of Australian snakebite (ASP‐18) , 2013, Journal of thrombosis and haemostasis : JTH.

[12]  P. Rojnuckarin,et al.  The role of prothrombin time (PT) in evaluating green pit viper (Cryptelytrops sp) bitten patients. , 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[13]  C. Kam,et al.  Green pit viper antivenom from Thailand and Agkistrodon halys antivenom from China compared in treating Cryptelytrops albolabris envenomation of mice. , 2012, Hong Kong medical journal = Xianggang yi xue za zhi.

[14]  M. Laffan,et al.  The use of fresh‐frozen plasma in England: high levels of inappropriate use in adults and children , 2011, Transfusion.

[15]  S. Duffull,et al.  Failure of antivenom to improve recovery in Australian snakebite coagulopathy. , 2009, QJM : monthly journal of the Association of Physicians.

[16]  G. Isbister,et al.  Clotting factor replacement and recovery from snake venom-induced consumptive coagulopathy , 2009, Intensive Care Medicine.

[17]  G. Mion,et al.  Antivenom therapy is efficient in Viperidae bites, fresh frozen plasma probably not. , 2009, The American journal of emergency medicine.

[18]  Julian White.  Snake venoms and coagulopathy. , 2005, Toxicon : official journal of the International Society on Toxinology.

[19]  A. Aggarwal,et al.  Low dose of snake antivenom is as effective as high dose in patients with severe neurotoxic snake envenoming , 2005, Emergency Medicine Journal.

[20]  G. Jelinek,et al.  The Effect of Adjunctive Fresh Frozen Plasma Administration on Coagulation Parameters and Survival in a Canine Model of Antivenom-treated Brown Snake Envenoming , 2005, Anaesthesia and intensive care.

[21]  Dong-Zong Hung,et al.  Taiwan's venomous snakebite: epidemiological, evolution and geographic differences. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[22]  F B Taylor,et al.  Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.

[23]  T. Intragumtornchai,et al.  The effects of green pit viper (Trimeresurus albolabris and Trimeresurus macrops) venom on the fibrinolytic system in human. , 1999, Toxicon : official journal of the International Society on Toxinology.

[24]  R. Clark,et al.  Recurrent and persistent coagulopathy following pit viper envenomation. , 1999, Archives of internal medicine.

[25]  D. Warrell.  WHO/SEARO Guidelines for the clinical management of snake bites in the Southeast Asian region. , 1999, The Southeast Asian journal of tropical medicine and public health.

[26]  D. Warrell,et al.  A randomized blinded comparison of two doses of antivenom in the treatment of Bothrops envenoming in São Paulo, Brazil , 1996 .

[27]  M. L. Santoro,et al.  A randomized 'blinded' comparison of two doses of antivenom in the treatment of Bothrops envenoming in São Paulo, Brazil. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[28]  J. Chan,et al.  Clinical features and hospital management of bites by the white-lipped green pit viper (Trimeresurus albolabris). , 1993, The Southeast Asian journal of tropical medicine and public health.

[29]  K. Silamut,et al.  Arboreal green pit vipers (genus Trimeresurus) of South-East Asia: bites by T. albolabris and T. macrops in Thailand and a review of the literature. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[30]  J. Chan,et al.  Bites by the white-lipped pit viper (Trimeresurus albolabris) and other species in Hong Kong. A survey of 4 years' experience at the Prince of Wales Hospital. , 1990, The Journal of tropical medicine and hygiene.

[31]  C. Mitrakul.  Effects of green pit viper (Trimeresurus erythrurus and Trimeresurus popeorum) venoms on blood coagulation, platelets and the fibrinolytic enzyme systems: studies in vivo and in vitro. , 1973, American journal of clinical pathology.